High risk for life-threatening adverse events of fluoroquinolones in young adults: a large German population-based cohort study
This study contributes real-world evidence to endpoint-specific differences of risks in patient subgroups which need to be considered to improve fluoroquinolone drug safety.
Authors
- Julia Wicherski (ORCID: https://orcid.org/0000-0001-9630-6239)
- Britta Haenisch (ORCID: https://orcid.org/0000-0002-4828-6058)
- Gabriela Brückner
- Cornelia Becker (ORCID: https://orcid.org/0000-0003-4161-4407)
- Andreas Schlotmann
- H. Schröder (ORCID: https://orcid.org/0009-0008-1447-6794)
- Winfried V. Kern (ORCID: https://orcid.org/0000-0003-2550-358X)
- Katrin Schüssel
- Jonas Peltner (ORCID: https://orcid.org/0000-0002-1682-7913)
Institutions
- Federal Institute for Drugs and Medical Devices (DE)
- University of Bonn (DE)
- University of Freiburg (DE)
- German Center for Neurodegenerative Diseases (DE)
- Wissenschaftliches Institut der AOK (DE)
Publication Details
- Journal
- BMC Medicine
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1186/s12916-025-03919-0
- Citations
- 11
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 15.34